Great COVID-19 Vaccine information from INDIA!

Bharat Biotech’s Covaxin vaccine yields positive Phase I data

This is Great News!  Yes, Sir!  Yes, Ma’am!  Great News from India!  What impresses me the most is Two-Fold.  First-No Adverse Effects on the Test Subjects.  Second-the large number of Test Subjects in Phase I is very, very impressive!  I can’t wait to see how well Phase II-III go.  I’m very excited for all Indians.  This maybe the right one for the World.  Good Luck!

Bharat Biotech’s Covaxin vaccine yields positive Phase I data

Here’s an Exert-

India-based Bharat Biotech’s Covid-19 vaccine candidate, Covaxin, has demonstrated an encouraging safety profile in a Phase I clinical trial conducted in the country.

Developed in alliance with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV), Covaxin is an inactivated vaccine candidate.

India’s regulatory agency granted approval for Phase I and II trials of the vaccine in June.

According to local media reports, preliminary Phase I trial results showed that the vaccine is safe. The trial’s principal investigator Dr Savita Verma at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak said that no adverse events were reported in subjects vaccinated at the site.